An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

Author： Bijl Arie   Breedveld Ferdinand   Antoni Christian   Kalden Joachim   Kary Sonja   Burmester Gerd   Beckmann Christina   Unnebrink Kristina   Kupper Hartmut  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.27, Iss.8, 2008-08, pp. : 1021-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori   Takahashi Masaaki   Torikai Eiji   Suzuki Motohiro   Ichikawa Tetsuya   Nagafusa Tetsuyuki   Koide Yukio   Nagano Akira  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite

Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment

By Tektonidou Maria   Serelis John   Skopouli Fotini  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 258-260

Springer Publishing Company

Access to resources Recommend Favorite

Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving infliximab treatment

By Kanayama Yasuhide   Kojima Toshihisa   Hirano Yuji   Shioura Tomone   Hayashi Masatoshi   Funahashi Koji   Ishiguro Naoki  

Modern Rheumatology, Vol. 20, Iss. 3, 2010-06 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite

Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn’s Disease: An Open-Label Pilot Study

By James Dustin   Seo Da   Chen Jiajing   Vemulapalli Caroline   Stone Christian  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1806-1810

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial

By Christensen Robin   Tarp Simon   Furst Daniel E   Kristensen Lars E   Bliddal Henning  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 6, 2013-12 ,pp. : 647-655

Future Medicine

Access to resources Recommend Favorite